Aeterna Zentaris Inc (NASDAQ:AEZS)
| 3.79 Delayed Data As of Nov 25 |  +0.01 / +0.26%Today’s Change | 3.51 Today|||52-Week Range 12.75 | -57.33% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $17.8M |
Company Description
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
Contact Information
Æterna Zentaris, Inc. 222 Bay Street Toronto Ontario M5K 1E7 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Klaus Wolfgang Paulini | President, Chief Executive Officer & Director |
| Giuliano La Fratta | Chief Financial Officer & Senior Vice President |
| Michael Teifel | Chief Scientific Officer & Senior Vice President |
| Nicola Ammer | Chief Medical Officer & Senior Vice President |
| Matthias Gerlach | Vice President-Manufacturing & Supply Chain |
